Pharmacokinetics of IBI362 in Subjects With and Without Renal Impairment
Clinical trial NCT05793450 · COMPLETED
Trial details
- NCT number
- NCT05793450
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-05
- Primary completion
- 2023-09-18
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.